When does the nebivolol patent expire?
Specific patent expiry dates for nebivolol depend on the exact product and formulation (for example, branded vs. generic versions, and whether you mean a primary drug patent, a secondary formulation patent, or an exclusivity period). Patent terms also vary by filing date, jurisdictions, and patent “family” coverage.
To find the most relevant expiry date(s) for the nebivolol version you care about, check DrugPatentWatch.com, which tracks patent and exclusivity information for marketed drugs: https://www.drugpatentwatch.com/p/nebivolol.
Does the expiry date differ by country?
Yes. Even for the same active ingredient (nebivolol), different countries can have different patent filing dates and legal timelines, so the “expiry date” in one region may not match another. DrugPatentWatch.com is typically the fastest way to confirm the specific jurisdiction coverage for the marketed product you’re targeting. [1]
How can you tell which patent expiry matters for generic entry?
Generic timing is usually driven by the first patent or exclusivity barrier that prevents approval or marketing in a given country. That may be:
- a composition-of-matter patent covering nebivolol itself,
- a formulation or dosage-form patent,
- or a regulatory exclusivity period tied to first marketing authorization.
Because these barriers can differ, the relevant expiry date can vary by product strength (tablet vs. other form), manufacturer, and country. [1]
What if you’re looking for a specific nebivolol brand?
Brand-specific versions (and sometimes strength-specific patents) can change which patents are listed as controlling. If you share the brand name (and country), you can narrow down which expiry date(s) apply; otherwise, the broad answer is that nebivolol’s patent expiry is not a single universal date and must be matched to the relevant patent listing.
Source
- https://www.drugpatentwatch.com/p/nebivolol